Sauna

🔥 Sauna Science: The Evidence-Based Guide to Heat Therapy

Sauna use has been practised for over two thousand years — but only in the past decade has science produced the quality of research needed to explain precisely what controlled heat exposure does to the human body. The findings are substantial. From large Finnish prospective cohort studies tracking tens of thousands of men and women, to randomised controlled trials examining cardiovascular function, the evidence base is growing in both volume and rigour.

This page is the Elysian Solara Sauna Knowledge Hub. It exists to give you one place — rigorously referenced, continuously updated — where you can understand sauna science as it actually stands. Not hype. Not anecdote. Evidence, properly qualified, with every major claim traceable to its primary source.

The landmark research in this field comes primarily from the Kuopio Ischaemic Heart Disease (KIHD) Risk Factor Study, a long-running Finnish prospective cohort based at the University of Eastern Finland. Led by Professor Tanjaniina Laukkanen and Professor Jari Laukkanen, this study has produced the most robust population-level evidence on sauna and health outcomes available anywhere in the world. Its findings — and the systematic reviews that have built upon them — form the backbone of what we know about sauna therapy.

At Elysian Solara, we operate on three principles: Evidence Over Opinion. Results Over Theory. Clarity Over Confusion. Everything on this page derives from verified, peer-reviewed research. Claims are qualified by their evidence strength. Limitations are stated honestly. This is not a sales page — it is a knowledge resource designed to become the most comprehensive and rigorously referenced sauna guide in Australia.

What You'll Learn on This Page

The physiological mechanisms triggered by heat stress — cardiovascular, hormonal and cellular
What the strongest epidemiological evidence says about sauna, cardiovascular health and mortality
The relationship between sauna frequency and all-cause mortality, dementia risk and longevity
How heat shock proteins (HSPs) work and what they mean for recovery, inflammation and cellular health
The metabolic and respiratory effects of regular sauna use, including CRP, IL-6 and lung function
What the evidence says — and does not say — about sauna and mental health
Evidence-based protocols: temperature, duration, frequency and timing
Who should not use a sauna and absolute contraindications supported by evidence
The difference between Finnish sauna, infrared sauna and Waon therapy, and why it matters for interpreting research

The Physiology of Heat Stress: What Happens When You Enter a Sauna

A traditional Finnish sauna operates at 80–100°C with 10–20% relative humidity. Within minutes of entering, your core body temperature begins to rise. Your cardiovascular system responds immediately: heart rate increases to between 100 and 150 beats per minute, cardiac output roughly doubles, and approximately 50–70% of blood flow is redirected to the skin to facilitate heat dissipation. This cardiovascular response is comparable in magnitude to that produced by moderate-intensity aerobic exercise — a fact that has driven significant research interest into sauna's potential as a passive cardiovascular conditioning tool.

The primary systemic response to heat stress is the activation of heat shock proteins (HSPs), particularly HSP70 and HSP90. These molecular chaperones are produced by virtually every cell in the body in response to thermal stress. Their function is protective: they refold damaged proteins, prevent protein aggregation, and support cellular repair mechanisms. HSP70 has been shown to suppress NF-κB-mediated vascular inflammation (Noble & Shen, 2012, Curr Vasc Pharmacol), cooperate with autophagy pathways to clear cellular debris (Dokladny et al., 2015, Autophagy), and support mitochondrial biogenesis via interaction with GLUT-4 signalling (Henstridge et al., 2016, J Appl Physiol). The repeated mild stress of regular sauna use — triggering HSP production without causing lasting damage — represents a classic hormesis response: a biological adaptation where controlled, repeated stress produces net positive adaptation.

Plasma volume also responds to heat exposure. Post-exercise sauna has been shown to expand plasma volume by approximately 7% after repeated sessions (Stanley et al., 2015, Eur J Appl Physiol), which may partly explain the cardiovascular adaptations observed in regular users. This effect is particularly relevant for athletic recovery and heat acclimation protocols.

Cardiovascular Health: What the Evidence Shows

The cardiovascular evidence for sauna is among the most robust in the field. The landmark 2015 paper by Laukkanen et al. (JAMA Internal Medicine, n=2,315 Finnish men followed for 20 years) established a striking dose-dependent association: compared to men who used a sauna once per week, those who used a sauna 4–7 times per week had a 40% lower risk of all-cause mortality (HR 0.60), a 50% lower risk of fatal cardiovascular events, and a 63% lower risk of sudden cardiac death (HR 0.37). These associations held after adjustment for conventional cardiovascular risk factors including smoking, blood pressure, BMI, and physical activity levels.

A 2018 follow-up study (Laukkanen et al., BMC Medicine, n=1,688 including women) confirmed that the cardiovascular mortality association extends to women, with dose-dependent benefit similar to that observed in men. The combined risk reduction for cardiovascular mortality reached 51% in women and 31% in men at the 4–7 times per week frequency.

The stroke evidence is similarly strong. Kunutsor et al. (2018, Neurology, n=1,628) found that frequent sauna use was associated with a 61% lower risk of stroke at 4–7 sessions per week (HR 0.39), compared to once-weekly use. This association was independent of established stroke risk factors.

For hypertension, a 2017 cohort study (Zaccardi et al., Am J Hypertension, n=1,621 men) found a 47% lower risk of incident hypertension in men using saunas 4–7 times per week (HR 0.53). Importantly, a 2016 RCT (Brunt et al., Journal of Physiology, n=36) demonstrated that passive heat therapy over 8 weeks produced a 35% increase in flow-mediated dilation (a measure of endothelial function) and reduced systolic blood pressure by approximately 12 mmHg — providing mechanistic evidence that supports the epidemiological associations.

The combination of high cardiorespiratory fitness and frequent sauna use appears to confer the greatest cardiovascular protection. Laukkanen et al. (2018, Prog Cardiovasc Dis, n=2,315) found that men with both high fitness and frequent sauna use had a sudden cardiac death hazard ratio of 0.23 — a reduction exceeding 75% compared to low-fitness, infrequent sauna users. This suggests that sauna and physical activity may work through complementary or synergistic mechanisms.

Key limitation: The strongest cardiovascular evidence comes from observational cohort studies of middle-aged Finnish men. While consistent and dose-dependent relationships are a strong indicator of biological effect, observational evidence cannot establish causation. No adequately powered mortality RCT exists in this space. Generalisability to women, other age groups and other ethnic populations should be stated honestly.

All-Cause Mortality and Longevity: The Finnish Evidence

The association between frequent sauna use and reduced all-cause mortality is one of the most replicated findings in this literature. The 2015 KIHD cohort data (CV-01) showed a 40% lower all-cause mortality at 4–7 sessions per week. A 2018 analysis (Kunutsor et al., Ann Med, n=2,315) found that the combination of high cardiorespiratory fitness and frequent sauna use was associated with approximately 80% lower all-cause mortality (HR ~0.20) — a remarkably large effect size, though one that must be interpreted with the inherent limitations of observational data.

The inflammation-mediated pathway has been explored in a 2022 prospective cohort study (Kunutsor et al., Eur J Epidemiol, n=2,302). Men with both frequent sauna use and low C-reactive protein (CRP) had the lowest all-cause mortality (HR ~0.40), suggesting that inflammation reduction may partly mediate the longevity association. This is consistent with the finding from Kunutsor et al. (2018, Ann Med) that regular sauna use is longitudinally associated with lower CRP (−0.20 mg/L) and IL-6 (−0.15 pg/mL) at 4–7 sessions per week.

A 2023 narrative review (Kunutsor & Laukkanen, Mayo Clin Proc) synthesised the evidence on sauna combined with multiple healthy lifestyle habits, finding that the combination of 3 or more beneficial health behaviours alongside frequent sauna was associated with 40–50% lower all-cause mortality — indicating that sauna functions as one component of a broader healthy lifestyle pattern rather than a standalone intervention.

Patrick & Johnson (2021, Experimental Gerontology) reviewed the hormesis and healthspan evidence, placing sauna within the broader context of deliberate stress-based longevity interventions. The authors conclude that regular sauna use fits a coherent biological model for extending healthspan, primarily through heat shock protein activation, cardiovascular conditioning, and autonomic nervous system modulation.

Brain Health: Dementia, Cognition and Neuroprotection

The dementia data is striking. A 2017 prospective cohort study (Laukkanen et al., Age and Ageing, n=2,315 men, follow-up 20 years) found that men who used a sauna 4–7 times per week had a 66% lower risk of dementia (HR 0.34) and a 65% lower risk of Alzheimer's disease (HR 0.35) compared to once-weekly users. This remained significant after adjustment for known dementia risk factors.

The proposed mechanisms — reviewed in a 2020 Age and Ageing commentary (PMC 7560162) — include improved cerebral blood flow, reduction of vascular risk factors, heat shock protein-mediated neuroprotection, and direct anti-inflammatory effects. A 2025 Frontiers in Neuroscience review (Smadja & Abreu) specifically explored the role of HSP-mediated neuroprotection in dementia and Long COVID — though this paper has not yet been verified in PubMed at the time of writing and should be treated as emerging evidence.

Key limitation: The dementia cohort is male-only. Under-ascertainment of cases in a historical Finnish cohort is possible. No human sauna RCT exists for cognitive endpoints — the mechanism evidence is currently mechanistic/observational only.

Heat Shock Proteins: The Cellular Mechanism

Heat shock proteins (HSPs) are among the most conserved stress-response proteins in biology. They function as molecular chaperones — assisting other proteins to fold correctly, preventing protein aggregation under stress, and supporting cellular repair. In the context of sauna and heat exposure, HSP70 and HSP90 are the most clinically relevant.

HSP70 has been shown to suppress NF-κB signalling, a key driver of vascular and systemic inflammation (Noble & Shen, 2012, Curr Vasc Pharmacol). It cooperates with autophagy — the cellular self-cleaning process — in a feedback relationship where heat-induced autophagy enhances HSP70 production and vice versa (Dokladny et al., 2015, Autophagy). HSP70 and HSP90 also regulate GLUT-4 translocation and mitochondrial biogenesis, offering a putative mechanism linking heat therapy to insulin sensitivity and metabolic health (Henstridge et al., 2016, J Appl Physiol; Archer et al., 2018, Phil Trans R Soc B).

The hormesis model — where mild, repeated cellular stress produces adaptive benefit — is the theoretical framework that unifies the cardiovascular, metabolic, cognitive and longevity effects of regular sauna use. Each session produces a brief, controlled stress sufficient to activate protective pathways (HSPs, heat acclimation, autonomic modulation) without causing lasting cellular damage.

Key limitation: No human sauna RCT has directly measured HSP-mediated outcomes as primary endpoints. The HSP evidence is currently mechanistic and should be presented as such — not as clinically proven benefit.

Metabolic Health: Inflammation, Glucose and Cardiovascular Fitness

The anti-inflammatory evidence is among the most well-supported secondary findings. Kunutsor et al. (2018, Ann Med, n=2,265) found that sauna frequency was independently associated with lower CRP and IL-6 levels, even after adjustment for physical activity and other confounders. At 4–7 sessions per week, CRP was reduced by 0.20 mg/L and IL-6 by 0.15 pg/mL — effects that, while modest in absolute terms, are biologically meaningful at a population level.

An RCT by Lee et al. (2022, Am J Physiol, n~102) is the strongest experimental evidence for combined sauna and exercise effects. Adding regular sauna sessions to an exercise programme produced improvements in VO₂ peak, HDL cholesterol and systolic blood pressure beyond those achieved with exercise alone over 8 weeks. The per-arm sample sizes were modest, and the duration was short — but this provides experimental evidence that sauna and exercise act through complementary mechanisms.

Henderson et al. (2021, Int J Environ Res Public Health) reviewed the cardiometabolic evidence in high-stress occupations, finding evidence of cortisol and catecholamine reduction associated with regular sauna use — suggesting autonomic nervous system modulation as a pathway through which sauna may reduce metabolic stress burden.

Respiratory Health: Pneumonia, COPD and Lung Function

A cluster of Finnish cohort studies has examined sauna use and respiratory health. Kunutsor et al. (2017, Respir Med, n=2,210) found a 41% lower risk of pneumonia at 4–7 sauna sessions per week (HR 0.59), with dose-dependent reduction. A companion paper (Kunutsor et al., 2017, Eur J Epidemiol) found a 40% lower risk of all respiratory disease. The proposed mechanisms include improved mucociliary clearance, heat-mediated immune modulation, and reduced inflammatory burden.

The COPD association is more recent: Kunutsor & Laukkanen (2023, Eur J Clin Invest, n=2,303) found a 33% lower risk of COPD in frequent sauna users, independent of smoking status — a meaningful finding given that smoking is the dominant COPD risk factor. A further study (Kunutsor et al., 2021, Int J Environ Res Public Health) found that the combination of high cardiorespiratory fitness and frequent sauna use reduced pneumonia hazard ratio to 0.35.

Mental Health: What the Evidence Actually Says

The mental health evidence requires careful qualification. The most-cited study is a 2016 RCT by Janssen et al. (JAMA Psychiatry, n=34, sham-controlled) which found that a single session of whole-body hyperthermia (WBH) reduced Hamilton Depression Rating Scale scores by 4.83 points versus sham, with effects lasting 6 weeks. This is genuinely promising — but the device used was a medical whole-body hyperthermia machine, not a consumer Finnish sauna. Assuming these results transfer to a domestic sauna would be scientifically unsound.

A 2013 pilot study (Hanusch et al., Am J Psychiatry, n=16) proposed a thermoregulatory-cooling mechanism involving 5-HT2A receptor modulation, which offers a plausible biological pathway. However, a 2019 narrative review (Hanusch & Janssen, Int J Hyperthermia) concluded that the evidence is "not yet sufficient for clinical recommendations." Cortisol and catecholamine reductions associated with sauna use (Henderson et al., 2021) suggest stress-regulatory benefit — but this is mechanistic, not clinical evidence for mood disorders.

What you can say with evidence: Regular sauna use is associated with reduced stress biomarkers. Whole-body hyperthermia shows early antidepressant promise in small trials. Consumer-sauna equivalence is biologically plausible but not yet proven.

What you cannot say: "Sauna treats depression." TGA advertising requirements prohibit therapeutic claims without TGA approval.

Athletic Recovery and Performance

Post-exercise sauna use is supported by a small but consistent body of experimental evidence. Stanley et al. (2015, Eur J Appl Physiol, n=19) demonstrated that sauna bathing after exercise expanded plasma volume by approximately 7% and increased time-to-exhaustion (TTE) in heat by 9.5% after repeated sessions. Kirby et al. (2021, Eur J Appl Physiol, n=11, controlled crossover) found that intermittent post-exercise sauna improved exercise capacity in a heat environment by 7%. Pokora et al. (2021, Int J Environ Res Public Health, n=12) found medium-term sauna heat acclimation improved performance markers in elite cross-country skiers.

The combination of sauna with exercise produced synergistic cardiovascular adaptations in the Lee et al. 2022 RCT, suggesting these modalities are complementary rather than interchangeable. The main mechanism for performance enhancement appears to be plasma volume expansion and improved cardiovascular efficiency under heat stress, rather than direct muscle recovery effects.

Key limitation: All performance studies involve small samples of trained athletes or physically active individuals. Extrapolation to general populations or to claims of "recovery" without the exercise context requires caution.

Infrared Sauna and Waon Therapy: The Evidence Gap

A critical point for accurate interpretation of sauna research: not all studies use the same modality. Traditional Finnish sauna operates at 80–100°C. Far-infrared (FIR) saunas typically operate at 45–60°C. Waon therapy — a Japanese far-infrared thermal therapy developed specifically for heart failure — is conducted at approximately 60°C. Medical whole-body hyperthermia devices used in clinical depression research are distinct again.

The Waon therapy evidence is genuinely interesting. Kihara et al. (2009, J Cardiol, n=129) found that Waon therapy reduced 5-year cardiovascular events and mortality in chronic heart failure patients. Fujita et al. (2011, Circ J, RCT n=45) found that Waon reduced oxidative stress, improved left ventricular ejection fraction and 6-minute walk distance in CHF patients. Sobajima et al. (2015, Int Heart J, n=49) extended this with quality-of-life improvements. Imamura et al. (2001, JACC, n=45) showed improved endothelial function with repeated FIR thermal therapy.

However, these findings cannot simply be applied to traditional Finnish sauna use, or vice versa. Modality differences in temperature, humidity, and heat transfer mechanism likely produce different physiological responses. Beever (2009, Can Fam Physician) and subsequent reviews have flagged this as a core limitation of the FIR evidence base.

Safety: Who Should and Should Not Use a Sauna

The safety evidence is well-established. The comprehensive 2001 review by Hannuksela & Ellahham (Am J Med) remains the standard safety reference and identifies both absolute and relative contraindications. Sauna is contraindicated in: unstable angina, recent myocardial infarction (within 3–4 months), severe aortic stenosis, decompensated heart failure, and during the first trimester of pregnancy.

The pregnancy contraindication is particularly important. Milunsky et al. (1992, JAMA, n=23,491) found that first-trimester hot tub or sauna exposure was associated with a 2.9-fold increase in neural tube defect risk (RR 2.9, 95% CI 1.7–5.0). A meta-analysis (Moretti et al., 2005, Epidemiology) pooled evidence to find an odds ratio of 1.93 (95% CI 1.53–2.42) for neural tube defects with first-trimester maternal hyperthermia. Harvey et al. (1981) and Chan et al. (2014) established a practical core temperature threshold of 38.9°C: pregnant women should not exceed this limit, which limits sauna sessions to approximately 10–15 minutes. The safest advice is to avoid sauna entirely in the first trimester and to consult a medical practitioner throughout pregnancy.

Alcohol and sauna is a documented high-risk combination. Kortelainen (1991, Am J Forensic Med Pathol) analysed 228 heat-related deaths in Finland between 1970 and 1986, finding alcohol as a contributory factor in the majority. Alcohol impairs thermoregulation and cardiovascular response to heat — it should not be consumed before or during sauna use.

For people with well-controlled hypertension, the evidence is broadly reassuring: the Zaccardi 2017 cohort found lower hypertension incidence in frequent sauna users, and the Brunt 2016 RCT found blood pressure reduction. However, individuals with uncontrolled hypertension should consult a medical practitioner before beginning regular sauna use.

Evidence-Based Protocols: How to Use a Sauna Effectively

The KIHD cohort data provides the most reliable guidance on frequency, as it is the only large dataset with dose-response outcomes. The greatest benefits were observed at 4–7 sessions per week — but meaningful benefit was also observed at 2–3 sessions per week compared to once-weekly use. For most people, 3–4 sessions per week represents a practical and evidenced starting point.

Temperature: Traditional Finnish sauna studies were conducted at 80–100°C (176–212°F). The evidence base for specific temperature protocols in consumer settings is limited; however, the sauna experience at lower temperatures (<70°C) is unlikely to produce the same degree of cardiovascular and heat shock protein response as the conditions studied in the KIHD cohort.

Duration: Single sessions in the cohort literature ranged from 5–20 minutes per session. The KIHD cohort documented mean session lengths of approximately 15 minutes. A single sauna session (Laukkanen et al., 2018, J Hum Hypertens, n=100) produced acute blood pressure reduction of −10.5/−7.0 mmHg. Practical guidance suggests 10–20 minutes per session with a 10-minute cool-down, repeating 2–3 rounds where tolerated.

Timing relative to exercise: The Lee et al. (2022) RCT used post-exercise sauna. The Stanley et al. (2015) plasma volume expansion study was also conducted post-exercise. Post-exercise sauna appears to be the best-evidenced timing for performance and recovery applications. Sauna before bed may improve sleep quality via core temperature regulation, though the sauna-and-sleep RCT evidence base is limited.

Finnish Sauna vs Infrared Sauna: Practical Implications

For consumers choosing between a traditional Finnish sauna and an infrared sauna, the key distinction is this: the large mortality and cardiovascular cohort data — the strongest evidence available — was collected in Finnish-population studies using traditional wet/dry sauna at 80–100°C. Far-infrared saunas at 45–60°C may produce meaningful benefits, particularly the Waon-type evidence in heart failure, but the specific population-level mortality and longevity associations cannot be directly attributed to FIR use based on current evidence.

Infrared saunas are more accessible for home use due to lower power requirements and lower operating temperatures. If the goal is general wellness and stress reduction, either modality may provide benefit. If the goal is to replicate the conditions studied in cardiovascular and longevity research, a traditional Finnish sauna operating at 80°C or above is the more evidence-aligned choice.

Key Evidence Caveats for Informed Decision-Making

Three structural limitations apply across the entire sauna evidence base and should inform how you interpret every claim on this page:

First: The strongest evidence is observational. The Finnish KIHD cohort provides robust, dose-dependent associations — but observational evidence, however large and well-adjusted, cannot establish causation. It is possible that healthy behaviours associated with sauna use (exercise, social engagement, health awareness) partly explain the observed associations. Researchers have adjusted for known confounders, but residual confounding cannot be excluded.

Second: Most landmark findings derive from Finnish men aged 42–60 at baseline. Generalisability to women, other ethnic groups, younger and older populations, and non-Finnish sauna users should be considered. The 2018 Laukkanen et al. BMC Medicine paper extends the cardiovascular finding to women, but the majority of the mechanistic and clinical literature remains male-dominated.

Third: Waon therapy, far-infrared therapy and medical whole-body hyperthermia are distinct modalities from traditional Finnish sauna. Their findings are promising and mechanistically relevant, but cross-applying them to consumer Finnish sauna use without acknowledging the modality difference is scientifically misleading.

Current Research Overview

The evidence base for sauna therapy is expanding. The following research areas are the most active and most likely to generate new clinical guidance over the next five years:

Sauna and peripheral arterial disease: Sastriques-Dunlop et al. (2025, Front Cardiovasc Med) reviewed the emerging evidence for sauna and PAD, suggesting plausible vascular benefit via improved endothelial function — preliminary but promising.
Heat therapy and neuroprotection: Smadja & Abreu (2025, Front Neurosci) reviewed HSP-mediated neuroprotection mechanisms relevant to neurodegeneration and Long COVID recovery — mechanistic; PubMed verification pending.
Acute cardiovascular responses: Yamasaki et al. (2026, Complement Ther Med) examined acute BP responses to sauna bathing — very recent; PMID unverified at time of writing.
Sauna in rheumatic disease: Fedorchenko et al. (2025, Rheumatol Int) reviewed sauna as an adjunct therapy in rheumatic disease, flagging both potential benefit and flare contraindications.
The absence of a Cochrane review: As of June 2026, no adequately powered Cochrane systematic review of sauna for cardiovascular or longevity outcomes exists. The strongest evidence remains large observational cohorts. This is a genuine gap in the evidence base that researchers and institutions are aware of.

Future Evidence Reviews

📋 Coming Soon — Structured evidence reviews in preparation for this pillar:

Sauna and Women's Health: What the Evidence Says (evidence gap — most cohort data is male)
Finnish Sauna vs Infrared Sauna: A Direct Evidence Comparison
Heat Shock Proteins and Ageing: The Mechanistic Evidence Base
Sauna Contraindications: A Clinical Reference Guide
Sauna and Respiratory Disease: Pneumonia, COPD and Immune Function

Primary Sources Referenced on This Page

All major claims on this page trace to verified primary sources. Key citations include:

Laukkanen T et al. (2015) — JAMA Internal Medicine — KIHD cohort landmark mortality study
Laukkanen JA et al. (2018) — Mayo Clinic Proceedings — Cardiovascular and other health benefits (systematic clinical review)
Kunutsor SK et al. (2018) — Neurology — Stroke risk reduction
Laukkanen T et al. (2017) — Age and Ageing — Dementia and Alzheimer's risk
Zaccardi F et al. (2017) — Am J Hypertension — Incident hypertension
Brunt VE et al. (2016) — Journal of Physiology — Passive heat therapy RCT
Kunutsor SK et al. (2017) — Respiratory Medicine — Pneumonia risk
Lee E et al. (2022) — Am J Physiol — Sauna and exercise RCT
Kunutsor SK et al. (2018) — Annals of Medicine — Combined CRF and sauna mortality
Hannuksela ML, Ellahham S (2001) — Am J Med — Safety review
Milunsky A et al. (1992) — JAMA — First-trimester hyperthermia and NTD risk
Janssen CW et al. (2016) — JAMA Psychiatry — Whole-body hyperthermia and depression
Noble EG, Shen G (2012) — Curr Vasc Pharmacol — HSP70 and vascular inflammation
Stanley J et al. (2015) — Eur J Appl Physiol — Plasma volume and sauna

This page is part of the Elysian Solara Wellness Hub — Australia's evidence-first resource for sauna, cold therapy, red light, PEMF, molecular hydrogen, hyperbaric oxygen, sleep, longevity and nervous system health. All content follows the Elysian Solara Evidence Standard: Evidence Over Opinion | Results Over Theory | Clarity Over Confusion.

Last updated: June 2026. This page will be updated as new research is published. Content is for educational purposes only and does not constitute medical advice. Consult a qualified healthcare practitioner before beginning any new health practice.

Item added to your cart